Agios Pharmaceuticals, Inc. 13F holders
238 funds reported a position in Agios Pharmaceuticals, Inc. in their 13F for the quarter ended 30 June 2026, together 66.1 million shares worth $2.46 billion. Against the quarter before, 32 opened a position, 95 added, 65 trimmed and 32 sold out; together they bought a net 2.9 million shares. The largest holders: BlackRock, Inc., Farallon Capital Management, L.l.c. and State Street Corp.
Funds holding238+4 on Q1 2026
Shares they held66.1Mworth $2.46 billion
Net bought on the quarter2.9M sharesabout $107.4 million at the funds' values
Funds buying to selling127 to 97opened or added, to cut or sold
Opened 32Added 95Held 43Trimmed 65Sold out 32
What each fund did in AGIO against its 13F for the quarter before; a change under 0.1% of a holding counts as held
Funds reporting a position in AGIO in their 13F, each quarter; hover a bar for the shares they held
Filed so far for the quarter to 30 September 2026
2,671 funds have filed their 13F for the quarter so far; the rest are due by 16 November 2026. Of those, 31 reported a position in Agios Pharmaceuticals, Inc.: 3 opened one, 14 added, 2 trimmed and 2 sold out, a net 1.8 million shares bought.
| Fund | Change in shares | Shares now | Status | Filing |
|---|---|---|---|---|
| Assenagon Asset Management S.A. | +1,678,502 | 1,886,412 | added | 13F |
| Y-Intercept (Hong Kong) Ltd | +85,516 | 85,516 | new | 13F |
| Harbor Capital Advisors, Inc. | +3,764 | 50,314 | added | 13F |
| Wealth Enhancement Advisory Services, LLC | +1,249 | 19,208 | added | 13F |
| Inspire Investing, LLC | +861 | 19,130 | added | 13F |
| Atria Investments, Inc | +569 | 14,602 | added | 13F |
| Hennion & Walsh Asset Management, Inc. | +485 | 34,059 | added | 13F |
| Bullock Wealth Management Group | +288 | 288 | new | 13F |
| GF Fund Management Co. Ltd | +275 | 1,517 | added | 13F |
| Assetmark, Inc. | +262 | 1,579 | added | 13F |
| SJS Investment Consulting Inc. | +239 | 370 | added | 13F |
| First Horizon Corp. | -122 | 320 | trimmed | 13F |
| Gamma Investing LLC | +100 | 638 | added | 13F |
| Financial Consulate, Inc. | +64 | 64 | new | 13F |
| Farther Finance Advisors, LLC | -62 | 422 | trimmed | 13F |
| Sterling Capital Management LLC | +61 | 1,197 | added | 13F |
| Essential Partners LLC | +42 | 599 | added | 13F |
| Nisa Investment Advisors, LLC | +38 | 1,396 | added | 13F |
| True Wealth Design, LLC | +8 | 314 | added | 13F |
| Thurston, Springer, Miller, Herd & Titak, Inc. | -241 | 0 | sold out | 13F |
| Wealth Enhancement Trust Services, Inc. | -77 | 0 | sold out | 13F |
The largest moves in the name among the funds that have filed, against each fund's previous 13F.
The well-known funds
Of the 44 funds followed here, 5 reported a position in Agios Pharmaceuticals, Inc. in a 13F for the quarter ended 30 June 2026. The largest: Geode Capital Management, 1.6 million shares worth $58.4 million, 0.0% of its reported book. New this quarter: Point72 Asset Management. Sold out: Millennium Management. In the quarter, 5 funds added or opened a position and 1 trimmed or sold out; together they bought a net 1.0 million shares, about $37.4 million at the funds' own value per share on 30 June 2026. A change under 0.1% of a holding counts as held.
| Fund | Shares | Value | Of its book | Change on the quarter | Status | Quarter ended | Filing |
|---|---|---|---|---|---|---|---|
| Geode Capital Management | 1,574,268 | $58.4 million | 0.0% | +106,358 | added | 30 June 2026 | 13F |
| Citadel Advisors | 732,687 | $27.2 million | 0.0% | +113,074 | added | 30 June 2026 | 13F |
| Two Sigma Investments | 536,380 | $19.9 million | 0.0% | +284,744 | added | 30 June 2026 | 13F |
| Point72 Asset Management | 506,344 | $18.8 million | 0.0% | +506,344 | new | 30 June 2026 | 13F |
| FMR LLC | 39,072 | $1.4 million | 0.0% | +29,951 | added | 30 June 2026 | 13F |
| Millennium Management | 0 | $0 | 0.0% | -32,144 | exited | 30 June 2026 | 13F |
Value is what the fund reported.
Read more
Change is shares against the fund's previous 13F; a fund with one filing read shows no change. 13Fs cover long US positions of managers above $100 million and are filed up to 45 days after the quarter.The largest holders
| Fund | Shares | Share of all | Value | Of its book | Change in shares | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 6,455,997 | 9.77% | $239.6 million | 0.00% | +701,040 | 13F |
| Farallon Capital Management, L.l.c. | 5,917,400 | 8.95% | $219.6 million | 1.30% | +233,400 | 13F |
| State Street Corp. | 3,533,633 | 5.35% | $131.1 million | 0.00% | +168,754 | 13F |
| Lynx1 Capital Management LP | 3,408,937 | 5.16% | $126.5 million | 14.62% | +797,369 | 13F |
| D. E. Shaw & Co., Inc. | 3,107,005 | 4.70% | $115.3 million | 0.07% | +425,836 | 13F |
| Vanguard Portfolio Management LLC | 2,898,197 | 4.38% | $107.6 million | 0.01% | +287,162 | 13F |
| Vanguard Capital Management LLC | 2,681,845 | 4.06% | $99.5 million | 0.00% | +49,529 | 13F |
| Armistice Capital, LLC | 2,400,000 | 3.63% | $89.1 million | 2.46% | -316,000 | 13F |
| Erste Asset Management GmbH | 2,154,900 | 3.26% | $82.0 million | 0.64% | -550,000 | 13F |
| Nomura Asset Management International Inc. | 2,110,809 | 3.19% | $78.3 million | 0.12% | +616,374 | 13F |
| Geode Capital Management, LLC | 1,574,268 | 2.38% | $58.4 million | 0.00% | +106,358 | 13F |
| Susquehanna International Group, LLP | 1,375,558 | 2.08% | $51.0 million | 0.04% | +30,605 | 13F |
| ADAR1 Capital Management, LLC | 1,288,053 | 1.95% | $47.8 million | 2.26% | +1,147,381 | 13F |
| BNP Paribas Asset Management Holding S.A. | 1,280,044 | 1.94% | $47.5 million | 0.05% | -300,796 | 13F |
| Dimensional Fund Advisors LP | 1,248,738 | 1.89% | $46.3 million | 0.01% | +97,124 | 13F |
| GW&K Investment Management, LLC | 1,206,615 | 1.83% | $44.8 million | 0.35% | -8,286 | 13F |
| Goldman Sachs Group Inc. | 1,150,932 | 1.74% | $42.7 million | 0.00% | +345,156 | 13F |
| UBS Group AG | 985,831 | 1.49% | $36.6 million | 0.01% | +853,291 | 13F |
| Morgan Stanley | 963,256 | 1.46% | $35.7 million | 0.00% | -4,269 | 13F |
| Nuveen, LLC | 873,560 | 1.32% | $32.4 million | 0.01% | +151,212 | 13F |
| Arrowstreet Capital, Limited Partnership | 810,530 | 1.23% | $30.1 million | 0.01% | +560,069 | 13F |
| Foresite Capital Management VI LLC | 785,000 | 1.19% | $29.1 million | 4.53% | +260,000 | 13F |
| Citadel Advisors LLC | 732,687 | 1.11% | $27.2 million | 0.02% | +113,074 | 13F |
| AQR Capital Management LLC | 684,340 | 1.04% | $25.4 million | 0.01% | +647,930 | 13F |
| Parkman Healthcare Partners LLC | 669,046 | 1.01% | $24.8 million | 2.55% | +265,521 | 13F |
| SCS Capital Management LLC | 612,850 | 0.93% | $22.7 million | 0.21% | no change | 13F |
| Qube Research & Technologies Ltd | 597,638 | 0.90% | $22.2 million | 0.03% | +409,971 | 13F |
| Northern Trust Corp. | 554,709 | 0.84% | $20.6 million | 0.00% | +45,437 | 13F |
| Defilade Capital Management, L.P. | 546,848 | 0.83% | $20.3 million | 2.72% | new | 13F |
| Charles Schwab Investment Management Inc. | 538,128 | 0.81% | $20.0 million | 0.00% | +61,096 | 13F |
| Two Sigma Investments, LP | 536,380 | 0.81% | $19.9 million | 0.01% | +284,744 | 13F |
| Rock Springs Capital Management LP | 532,563 | 0.81% | $19.8 million | 0.96% | -266,600 | 13F |
| Schonfeld Strategic Advisors LLC | 520,083 | 0.79% | $19.3 million | 0.10% | +320,022 | 13F |
| Bank of America Corp. | 507,869 | 0.77% | $18.8 million | 0.00% | -31 | 13F |
| Point72 Asset Management, L.P. | 506,344 | 0.77% | $18.8 million | 0.03% | new | 13F |
| Jane Street Group, LLC | 492,598 | 0.75% | $18.3 million | 0.01% | -192,642 | 13F |
| Legal & General Group Plc | 434,719 | 0.66% | $16.1 million | 0.00% | +10,804 | 13F |
| Vanguard Fiduciary Trust Co. | 395,868 | 0.60% | $14.7 million | 0.00% | +13,847 | 13F |
| Panagora Asset Management Inc. | 373,931 | 0.57% | $13.9 million | 0.04% | +135,463 | 13F |
| Kennedy Capital Management LLC | 373,230 | 0.56% | $13.9 million | 0.24% | +97,774 | 13F |
| JPMorgan Chase & Co. | 359,756 | 0.54% | $13.8 million | 0.00% | +208,198 | 13F |
| Connor, Clark & Lunn Investment Management Ltd. | 359,550 | 0.54% | $13.3 million | 0.03% | -90,543 | 13F |
| Squarepoint Ops LLC | 321,138 | 0.49% | $11.9 million | 0.02% | +112,250 | 13F |
| Ensign Peak Advisors, Inc | 297,630 | 0.45% | $11.0 million | 0.02% | +291,060 | 13F |
| BNP Paribas Financial Markets | 269,383 | 0.41% | $10.0 million | 0.01% | -58,074 | 13F |
| Algert Global LLC | 248,007 | 0.38% | $9.2 million | 0.11% | -20,428 | 13F |
| Price T Rowe Associates Inc. | 218,966 | 0.33% | $8.1 million | 0.00% | -79,817 | 13F |
| Palo Alto Investors LP | 213,601 | 0.32% | $7.9 million | 1.09% | no change | 13F |
| Assenagon Asset Management S.A. | 207,910 | 0.31% | $7.7 million | 0.01% | 13F | |
| Tetragon Partners GP Ltd | 205,579 | 0.31% | $7.6 million | 1.24% | +40,740 | 13F |
The 50 largest of the 238 funds that reported a position in AGIO in their 13F for the quarter ended 30 June 2026, by the value each reported.
Read more
Share of all is the fund's part of all the shares the funds reported. Change is shares against the fund's 13F for the quarter before. A 13F lists a manager's long positions in US-listed shares at the quarter's end. What is a 13F?Options the funds reported on AGIO
| Fund | Option | Shares under the options | Value of those shares | Quarter ended | Filing |
|---|---|---|---|---|---|
| Citadel Advisors | Calls | 91,700 | $3.4 million | 30 June 2026 | 13F |
| Citadel Advisors | Puts | 88,800 | $3.3 million | 30 June 2026 | 13F |
A 13F lists calls and puts by the shares they cover and what those shares were worth at the quarter's end, not what the options cost.
Read more
They are not counted in the holdings above. A put gains when the stock falls, a call when it rises, and a fund may hold either to hedge.Schedule 13D and 13G filed on the name, last twelve months
| Filed | Schedule | Who | Holding | Of the class | Event date | Rule or purpose | Filing |
|---|---|---|---|---|---|---|---|
| 3 August 2026 | 13G/A | Farallon Capital Management, L.L.C. and 57 others | 5.9 million | 9.9% | 30 June 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 2 July 2026 | 13G | D. E. Shaw & Co., L.P. and 3 others | 3.0 million | 5.1% | 25 June 2026 | passive, under 20% (13d-1(c)) | EDGAR |
| 15 May 2026 | 13G/A | Armistice Capital, LLC and 3 others | 2.7 million | 4.6% | 31 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 6 May 2026 | 13G | Lynx1 Capital Management LP and 3 others | 3.0 million | 5.1% | 29 April 2026 | passive, under 20% (13d-1(c)) | EDGAR |
| 29 April 2026 | 13G | Vanguard Capital Management and 1 other | 3.1 million | 5.3% | 31 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 26 March 2026 | 13G/A | The Vanguard Group and 1 other | 0 | 0.0% | 13 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 17 February 2026 | 13G | Armistice Capital, LLC and 3 others | 3.0 million | 5.2% | 31 December 2025 | passive, institutional (13d-1(b)) | EDGAR |
| 9 February 2026 | 13G/A | Farallon Capital Partners, L.P. and 61 others | 5.2 million | 8.8% | 31 December 2025 | passive, under 20% (13d-1(c)) | EDGAR |
| 9 February 2026 | 13G | State Street Corporation and 1 other | 3.1 million | 5.3% | 31 December 2025 | passive, institutional (13d-1(b)) | EDGAR |
| 5 December 2025 | 13G/A | Bellevue Group AG and 3 others | 0 | 0.0% | 19 November 2025 | passive, institutional (13d-1(b)) | EDGAR |
| 14 November 2025 | 13G/A | Paradigm BioCapital Advisors LP and 7 others | 2.9 million | 4.9% | 30 September 2025 | passive, under 20% (13d-1(c)) | EDGAR |
A Schedule 13D is filed by anyone who crosses 5% of a class with intent to influence; a 13G by a passive holder.
Read more
Amendments (/A) report a change, including an exit to zero. Holding and percentage are as the filer stated them on the cover page; the purpose is the filer's own words, cut short. 13D and 13GFails to deliver
| Settlement date | Shares failed | Price | File |
|---|---|---|---|
| 17 August 2026 | 94 | $33.56 | SEC |
Shares that failed to deliver at settlement, per day, from the SEC's half-month files, which arrive about two weeks after the period.